Stockscreener 앱 받기
0.313
2.14%
-0.0054
전일 마감가:
$0.3184
열려 있는:
$0.325
하루 거래량:
1.20M
Relative Volume:
0.60
시가총액:
$8.22M
수익:
-
순이익/손실:
$-16.26M
주가수익비율:
-0.2649
EPS:
-1.1814
순현금흐름:
$-13.50M
1주 성능:
-6.43%
1개월 성능:
+12.49%
6개월 성능:
-87.78%
1년 성능:
-93.59%
1일 변동 폭
$0.3106
$0.325
1주일 범위
$0.30
$0.3402
52주 변동 폭
$0.2602
$4.9399
인텐시티 테라퓨틱스 Stock (INTS) Company Profile
명칭
Intensity Therapeutics Inc
전화
203-221-7381
주소
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.3153 | 8.73M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.39 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.52 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.26 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.31 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
292.00 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
인텐시티 테라퓨틱스 주식(INTS)의 최신 뉴스
What analysts say about Intensity Therapeutics Inc. stockFree Trading Psychology Coaching - jammulinksnews.com
What drives Intensity Therapeutics Inc. stock priceBreakthrough capital growth - jammulinksnews.com
The Business Case For Buying Intensity Therapeutics Inc (NASDAQ: INTS) Stock Now - Stocksregister
Is Intensity Therapeutics Inc. a good long term investmentUnbelievable profit margins - jammulinksnews.com
Intensity Therapeutics Inc. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
SBXD.U Stock Analysis and ForecastFree Investment Case Studies - Jammu Links News
Is EUDA a good long term investmentFree Investment Community - Jammu Links News
What drives World Kinect Corporation stock priceRapid portfolio appreciation - Jammu Links News
Intensity Therapeutics shareholders elect director and approve auditor at annual meeting - Investing.com
Intensity Therapeutics Holds Annual Stockholders’ Meeting - TipRanks
Is AFJKU a good long term investmentDynamic investment growth - Jammu Links News
why afloki(angryfloki) will explodeFree Access to Community - Newser
How LGCL stock performs during market volatilityCapital Efficient Investment Tips - Newser
Why BNAIW stock attracts strong analyst attentionFree Investment Community - Newser
How CAMP stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes AACT.WS stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Why Mandatory Common Exchange Trust Preferred Security stock attracts strong analyst attention2x Return Forecast - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser
What makes Capricor Therapeutics Inc. stock price move sharplyDaily Stock Radar - Newser
How Intensity Therapeutics Inc. stock performs during market volatilityFree Financial Group - Newser
What makes Intensity Therapeutics Inc. stock price move sharplySmart Money Signals - Newser
Why Herc Holdings Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser
How Apple Hospitality REIT Inc. stock performs during market volatilityFree Group Entry - Newser
Why REXR.PRC stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser
How Ichor Holdings Ltd. stock performs during market volatilityHigh Accuracy Alerts - Newser
How LANDO stock performs during market volatilityTop Growth Low Risk Stocks - Newser
What makes flyExclusive Inc. Equity Warrant stock price move sharplySafe and Smart Investment Picks - Newser
INTS Stock: Exploring Intensity Therapeutics Inc’s Growth - investchronicle.com
OP’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Intensity Therapeutics Inc’s Shares Reel: -85.34% Quarterly Revenue Decline Amid 7.38M Market Cap - investchronicle.com
Intensity Therapeutics Announces $2.3 Million Public Offering of Common Stock - Global Legal Chronicle
Oncology Innovation Just Hit a Turning Point — Here’s What to Watch - The Malaysian Reserve
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch - The Globe and Mail
Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST) - Nasdaq
INTS SEC FilingsINTENSITY THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire UK
Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds - The Globe and Mail
Why Is Intensity Therapeutics Stock (INTS) Down 50% Today? - The Globe and Mail
Intensity Therapeutics Completes $1.9 Million Stock Offering - TipRanks
Intensity Therapeutics Stock Falls 44% Today Should You Buy the Dip or Stay Away - thekhabrilal
인텐시티 테라퓨틱스 (INTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.65%
자본화:
|
볼륨(24시간):